zp8396
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 19, 2021 (NCT05096598)
Timeline
Indications
Mechanism of action
- Islet amyloid polypeptideSupplementation
IAPP supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314864 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06926842 | Phase 2 | Apr 22, 2025 | Parexel, Zealand Pharma |
| NCT07076030 | Phase 1 | Apr 15, 2025 | Humboldt University, ICON, Zealand Pharma |
| NCT06662539 | Phase 2 | Dec 6, 2024 | Parexel, Zealand Pharma |
| NCT05613387 | Phase 1 | Nov 7, 2022 | Zealand Pharma |
| NCT05096598 | Phase 1 | Oct 19, 2021 | Zealand Pharma |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zealand Pharma | For profit | 5 | 5 | 2 | 2021 |
| Parexel | For profit | 2 | 0 | 1 | 2024 |
| Humboldt University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| ICON | For profit | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1